U.S. attorney general imposes moratorium on federal executions
Reuters
Published Jul 01, 2021 07:26PM ET
Updated Jul 01, 2021 08:31PM ET
By Sarah N. Lynch and Eric Beech
WASHINGTON (Reuters) -U.S. Attorney General Merrick Garland on Thursday imposed a moratorium on federal executions while the Justice Department continues its review of the death penalty, the department said in a statement.
"The Department of Justice must ensure that everyone in the federal criminal justice system is not only afforded the rights guaranteed by the Constitution and laws of the United States, but is also treated fairly and humanely," Garland said in the statement. "That obligation has special force in capital cases."
Garland's predecessor, William Barr, resumed use of capital punishment last year after a 17-year hiatus.
In the waning months of the administration of President Donald Trump, the Bureau of Prisons (BOP) carried out 13 executions, as the COVID-19 pandemic raged throughout the federal prison system and sickened some of the prisoners on death row and even some of their attorneys.
The 13 executions during Trump's tenure -- carried out beginning in July 2020 and ending just days before Trump left office on Jan. 20, 2021 -- exceeded the executions undertaken by any other U.S. president since the 19th century.
Under Barr's directive, the BOP switched to using pentobarbital as part of a new single-drug protocol to administer the lethal injection. Previously, the government had used a combination of three drugs to carry out executions, but that protocol was abandoned because of a shortage of one of the drugs, an anesthetic called sodium thiopental.
Defense lawyers and capital punishment critics have raised concerns about the use of pentobarbital, which can cause a drowning sensation as it rapidly damages capillaries in the lungs, according to autopsies of executed inmates.
Garland said on Thursday that he was directing Deputy Attorney General Lisa Monaco to lead a review that will assess, among other things, the Justice Department's 2019 single-drug protocol as well as "the risk of pain and suffering associated with the use of pentobarbital."
The review will also scrutinize changes the Justice Department made to its regulations in November 2020 that expanded the methods it could use to carry out executions.
Ruth Friedman, director of the Federal Capital Habeas Project, said in a statement that the moratorium on federal executions "is one step in the right direction, but it is not enough."
"President Biden, with the support of the Department of Justice, can and should commute all federal death sentences," she said. Without such a step, she said, it could "pave the way for another unconscionable bloodbath like we saw last year.”
President Joe Biden, a Democrat, pledged during his campaign to support legislation to end the death penalty. Garland has previously said he has concerns about the practice, though some criminal justice reform advocates have criticized the administration for not taking swift enough action.
Get The News You Want
Garland said last month he was personally reviewing the department's processes dealing with the death penalty. He told his Senate confirmation hearing in February he had concerns about innocent people being executed and about the disparate impact of the death penalty on Black Americans.
There are currently 46 inmates on federal death row, according to the Death Penalty Information Center. Of those, 20 are white, 18 are Black, seven are Latino and one is Asian.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.